SCHEMBL24936157

SCHEMBL24936157

COc1nccc(OCC2(O)CN(C(=O)OC(C)(C)C)C2)c1-c1cc(N)n[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 7/20 0.45
KCNH2 Q12809 4/20 0.45
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
MET P08581 1/20 0.34
AXL P30530 1/20 0.34
HSD17B10 Q99714 1/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CFTR P13569 1/20 0.33
HTT P42858 1/20 0.33
TBK1 Q9UHD2 1/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24936205 0.91 CHEK1 (0.44) CHEK1KCNH2ALOX5APFEN1PDE4A
SCHEMBL24936297 0.90 CHEK1 (0.42) CHEK1KCNH2ALOX5APFEN1PDE4A
SCHEMBL24936247 0.81 CHEK1 (0.73) CHEK1KCNH2
SCHEMBL24935467 0.79 CHEK1 (0.47) CHEK1KCNH2HSD17B10CCNT1CDK9
SCHEMBL24936150 0.76 KCNH2 (0.57) CHEK1KCNH2AXL
SCHEMBL24936208 0.75 CHEK1 (0.43) CHEK1KCNH2
SCHEMBL24935425 0.74 CHEK1 (0.44) CHEK1KCNH2
SCHEMBL24936252 0.72 CHEK1 (0.46) CHEK1KCNH2MEN1KMT2A
SCHEMBL24936259 0.72 KCNH2 (0.50) CHEK1KCNH2HSD17B10CCNT1CDK9
SCHEMBL24936201 0.71 CHEK1 (0.42) CHEK1KCNH2HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11564920-B2 5-heteroaryl-1H-pyrazol-3-amine derivative Sumitomo Pharma Co., Ltd. (JP) 2023-01-31 US disclosed
US-20230025065-A1 5-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11564920-B2 5-heteroaryl-1H-pyrazol-3-amine derivative CHEK1, CHEK2, RB1 CHEK1 1/4885KCNH2 2700/4885ALOX5AP 4812/4885
US-20230025065-A1 5-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE CHEK1, CHEK2, RB1 CHEK1 1/4885KCNH2 2700/4885ALOX5AP 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.